BCR Antikörper (Biotin)
-
- Target Alle BCR Antikörper anzeigen
- BCR (Breakpoint Cluster Region (BCR))
-
Reaktivität
- Alle Spezies
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser BCR Antikörper ist konjugiert mit Biotin
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Aufreinigung
- The splenic lymphocytes from BALB/c mouse, immunized with CML-KLH were fused to myeloma P3U1 cells. The cell line (CMS-10) with positive reaction wasgrown in ascitic fluid of BALB/c mouse, from which the antibody was purified byProtein G affinity chromatography and conjugated.
- Immunogen
- CML-KLH
- Klon
- CMS-10
- Isotyp
- IgG1
- Top Product
- Discover our top product BCR Primärantikörper
-
anti-Breakpoint Cluster Region (BCR) (AA 139-280) antibody
BCR Reaktivität: Human WB, ELISA, IHC, FACS, ICC, Neut Wirt: Maus Monoclonal 1E11G12 unconjugated
anti-Breakpoint Cluster Region (BCR) (AA 182-280) antibodyBCR Reaktivität: Human WB, ELISA, IF, PLA Wirt: Maus Monoclonal 2E5 unconjugated
anti-Breakpoint Cluster Region (BCR) (pTyr360) antibodyBCR Reaktivität: Human, Maus, Ratte WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Breakpoint Cluster Region (BCR) (pTyr177) antibodyBCR Reaktivität: Human, Maus WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Breakpoint Cluster Region (BCR) (AA 1-300) antibodyBCR Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Breakpoint Cluster Region (BCR) antibodyBCR Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Breakpoint Cluster Region (BCR) (pTyr177) antibodyBCR Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Breakpoint Cluster Region (BCR) (AA 1-1076) antibodyBCR Reaktivität: Human WB, PLA Wirt: Kaninchen Polyclonal unconjugated
anti-Breakpoint Cluster Region (BCR) (N-Term) antibodyBCR Reaktivität: Human, Maus WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Breakpoint Cluster Region (BCR) (AA 331-380), (pTyr360) antibodyBCR Reaktivität: Human, Maus WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Working dilution for immunohistochemistry: 5-10ug/ml, for ELISA: 0.1-1.0ug/ml
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.25 mg/ml
- Buffer
- PBS (containing 2% Block Ace as a stabilizer, 0.1% Proclin as a bacteriostat)
- Konservierungsmittel
- ProClin
- Lagerung
- -20 °C
-
- Target
- BCR (Breakpoint Cluster Region (BCR))
- Andere Bezeichnung
- CML (BCR Produkte)
- Synonyme
- si:dkey-83d9.7 antikoerper, zK83D9.7 antikoerper, BCR antikoerper, ALL antikoerper, BCR1 antikoerper, CML antikoerper, D22S11 antikoerper, D22S662 antikoerper, PHL antikoerper, 5133400C09Rik antikoerper, AI561783 antikoerper, AI853148 antikoerper, mKIAA3017 antikoerper, breakpoint cluster region antikoerper, BCR, RhoGEF and GTPase activating protein antikoerper, bcr antikoerper, BCR antikoerper, Bcr antikoerper
- Hintergrund
- Reaction of protein amino groups with glucose leads, through the early products such as a Schiff baseand Amadori rearrangement products, to the formation of advanced glycation end products (AGEs). Recent immunological studies using anti-AGEs antibody (6D12) demonstrated the presence of AGEs-modifiedproteins in several human tissues: human lens (nondiabetic and noncataractous), renal proximaltubules in patients with diabetic nephropathy and chronic renal failure, diabetic retina, peripheral nerves of diabetic neuropathy, atherosclerotic lesions of arterial walls, beta2-microglobulin forming amyloid fibrils in patients with hemodialysis-related amyloidosis, senileplaques of patients with Alzheimer
- Pathways
- Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling
-
